lexeotx.com (LXEO) Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi
Lexeo Therapeutics (LXEO) aksiyalarining grafigi alohida uzoq muddatli qarzdorlikning kapitalga nisbati dinamikasini aks ettiradi, u 0.02 darajasida turibdi. Kompaniyaning ishlab chiqarishi ifloslanishni bartaraf etish uchun robotlashtirilgan liniyalar va steril bioreaktorlarga tayanadi. Firma viral vektorlar uchun noyob patentlarga ega bo'lib, kardiomiopatiyalar va Altsgeymer kasalligi uchun DNKni tuzatish usullarini ishlab chiqmoqda. Yangi tashkil etilayotgan ilmiy markaz miya va yurak patologiyalarini davolash tizimiga ilg'or ishlanmalarni integratsiya qilish imkonini beradi.
Lexeo Therapeutics Inc. (LXEO) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi tafsilotlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning kapitalga nisbati Lexeo Therapeutics|LXEO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi Lexeo|LXEO - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Lexeo Therapeutics, Inc.|LXEO - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Lexeo Therapeutics|Oraliq qoplash koeffitsiyenti lexeotx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning jamlanma tahlili:LXEO (lexeotx.com)
Ushbu ko'rsatkich kapital tuzilmasidagi uzoq muddatli qarzlar ulushini o'lchaydi, bu esa moliyaviy leverajni va qarz yuklamasi xavfini baholash imkonini beradi. Uzoq muddatli qarzning kapitalga nisbatini tahlil qilish orqali investor barqaror bemorlar bazasi yo'qligida rivojlanishi ventura moliyalashtirish va FDA tasdig'iga bog'liq bo'lgan Lexeo Therapeutics (LXEO) kompaniyasining barqarorligini aniqlaydi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TEM (Tempus)|Uzoq muddatli qarzning o'z kapitaliga nisbati Qiagen Group (QGEN)|Isis Pharmaceuticals - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati RGEN (Repligen Corporation)|Uzoq muddatli qarzning kapitalga nisbati aviditybiosciences.com RNA|CRSP - Uzoq muddatli qarzning o'z kapitaliga nisbati|WGS: Uzoq muddatli qarzning o'z kapitaliga nisbati|RARE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Beam Tx (BEAM)|Uzoq muddatli qarzning o'z kapitaliga nisbati SRPT|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi TWST (twistbioscience.com)|Uzoq muddatli qarzning kapitalga nisbati TXG|NTLA - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Stoke STOK|BioLife (BLFS) - Uzoq muddatli majburiyatlarning kapitalga nisbati|WVE: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti MAZE (mazetx.com)|SION (Sionna Therapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PRME: Uzoq muddatli kreditlarning kapitalga nisbati|TSHA (Taysha) - Uzoq muddatli qarzning kapitalga nisbati|QURE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati MGTX|RGNX - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Solid Biosciences SLDB|Uzoq muddatli qarzning kapitalga koeffitsiyenti OCGN|Pacific Biosciences of California - Uzoq muddatli qarzning kapitalga nisbati|BNTC - Uzoq muddatli qarzning kapitalga nisbati|Design Therapeutics (DSGN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati RCKT (rocketpharma.com)|FDMT (4D Molecular Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Korro Bio, Inc KRRO|Uzoq muddatli qarzning o'z kapitaliga nisbati EDIT (Editas)|Uzoq muddatli qarzning kapitalga nisbati Silence Therapeutics Corp (SLN)|ProQR Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati CDXS (Codexis Inc)|Sangamo Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Nautilus Biotechnology NAUT|MGX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Precision BioSciences Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Generation Bio Co|boundlessbio.com (BOLD) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Exicure, Inc. (XCUR)|Uzoq muddatli qarzning o'z kapitaliga nisbati IMNN (imunon.com)|Phio Pharmaceuticals Corp. - Uzoq muddatli qarzning o'z kapitaliga nisbati|MBIO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|TransCode - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Bionano Genomics, Inc.|Applied DNA Sciences, Inc. (APDN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati bluebird bio Inc. (BLUE)|IPA (ImmunoPrecise Antibodies Ltd) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi OMGA (Omega Therapeutics Corp)|Uzoq muddatli qarzning o'z kapitaliga nisbati Singular Genomics Systems (OMIC)|regulusrx.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati SYRS (Syros Pharmaceuticals, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Telesis Bio Inc. TBIO|TCON - Uzoq muddatli qarzning o'z kapitaliga nisbati|UBX: Uzoq muddatli qarzning o'z kapitaliga nisbati